Dec. 4, 2002 (Chicago) - A radiopharmaceutical-imaging agent - ioflupane (I123-FP-CIT) - used with single photon emission computed tomography (SPECT) is "98% accurate" for early diagnosis of Parkinson ...
SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced the publication of the first human SPECT images ...
Medical Device Network on MSN
FDA clears Spectrum Dynamics’ Veritas.AI platform
Veritas.AI is designed to advance the functionality of Spectrum Dynamics’ VERITON-CT scanner for nuclear imaging.
Brain SPECT imaging can differentiate between depression and cognitive disorders, new report reveals
Neuroimaging of decreased blood flow in specific regions of the brain can differentiate between depression and cognitive disorders, according to a new report in the Journal of Alzheimer's Disease Does ...
A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more personalized treatment.
U-SPECT 7 CT from MILabs (a Rigaku company) offers unmatched preclinical dynamic and whole body Single Photon Emission Computed Tomography (SPECT) performance, integrated with diagnostic micro-CT.
Bone SPECT/CT imaging – the integration of functional single photon emission computed tomography with anatomical computed tomography – represents a significant advancement in the evaluation of foot ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results